StockClub

RAFA

RAFARafarma Pharmaceuticals, Inc.$ --
Rafarma Pharmaceuticals, Inc.

Rafarma Pharmaceuticals, Inc.

RAFA

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2025FY2024 Q4
Revenue
0M USD
YoY +26.4%
Operating Income
0M USD
YoY +164.5%
Net Income
0M USD
YoY +117.6%
EPS
0$
YoY -25.0%

Revenue

$9.1M
FY2022 Q4$60M
$60M
Q4
FY2023 Q1$10.9M
$10.9M
Q1
FY2023 Q2$16.6M
$16.6M
Q2
FY2023 Q4$16.8M
$16.8M
Q4
FY2024 Q1$108,000
$108,000
Q1
FY2024 Q2$293,000
$293,000
Q2
FY2024 Q3$8.9M
$8.9M
Q3
FY2024 Q4$9.1M
$9.1M
Q4
Actual
$-7.6M (-45.5%)

Net Income

$306,000
FY2022 Q4$5M
$5M
Q4
FY2023 Q1$1.8M
$1.8M
Q1
FY2023 Q2$918,000
$918,000
Q2
FY2023 Q4$952,000
$952,000
Q4
FY2024 Q1$17,000
$17,000
Q1
FY2024 Q2$85,000
$85,000
Q2
FY2024 Q3$232,000
$232,000
Q3
FY2024 Q4$306,000
$306,000
Q4
Actual
$-646,000 (-67.9%)

Surprise History

Actual RevenueAnalyst Estimate
FY2019
Actual:$11.4M
FY2019
$11.4M
FY2020
Actual:$74.7M
FY2020
$74.7M
FY2021
Actual:$77.4M
FY2021
$77.4M
FY2022
Actual:$64.3M
FY2022
$64.3M
FY2023
Actual:$10.1M
FY2023
$10.1M
FY2024
Actual:$9.1M
FY2024
$9.1M

Analyst Estimates

No forecast data